- OLE study - Open Label Extension study phase Clarinet with lanreotide Autogel 120 mg in metastatic enteropancreatic neuroendocrine tumors2016 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. 20140128Publication without faculty affiliation
- Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension2024 | Publication without faculty affiliation
- Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study2016 | First Faculty of Medicine